Mirum Pharmaceuticals, Inc. MIRM Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s net change in cash?
- Mirum Pharmaceuticals, Inc. (MIRM) reported net change in cash of $28.48M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s net change in cash changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s net change in cash increased by 366.6% year-over-year, from -$10.68M to $28.48M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s net change in cash?
- Over 2 years (2022 to 2025), Mirum Pharmaceuticals, Inc.'s net change in cash has grown at a 374.8% compound annual growth rate (CAGR), from -$3.34M to $75.24M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.